Clinical

Dataset Information

0

Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer


ABSTRACT: A Phase I/II study of an in-situ therapeutic cancer vaccine. Vaccines contain a source of antigen and and adjuvant. In this study the source of tumor antigen comes from the killing of a selected tumor by cryoablation (killing using extreme cold) and the adjuvant is intentionally mis-matched immune cells (AlloStim-TM) engineered to produce inflammatory cytokines.

DISEASE(S): Ovarian Cancer,Prostatic Neoplasms,Sarcoma,Melanoma,Colorectal Cancer,Non-small Cell Lung Cancer,Colorectal Neoplasms,Prostate Cancer,Ovarian Neoplasms,Breast Cancer,Solid Tumors Stage Ii, Stage Iii And Stage Iv

PROVIDER: 2084684 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2069261 | ecrin-mdr-crc
| 2185135 | ecrin-mdr-crc
| 2136197 | ecrin-mdr-crc
2022-09-10 | GSE213034 | GEO
2022-08-23 | GSE201590 | GEO
2024-11-19 | GSE282249 | GEO
2017-05-31 | GSE83889 | GEO
2016-04-01 | GSE79828 | GEO
2022-10-30 | E-MTAB-10998 | biostudies-arrayexpress
2016-04-01 | E-GEOD-79828 | biostudies-arrayexpress